Immunochem
ActiveSummary
Immunochem has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €513k and a net result of €96k. Equity is growing by ~18.3% per year across the filed fiscal years. Its solvency ranks better than 47% of 11389 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability78▲+23
Solvency63▼-1
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.02 against 1.84 in 2024; short-term debt: 39.5% and cash: 5.6% of total assets), but 61.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
38.3%
Return on assets
7.1%
Age of the figures
15 mo
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
2 d late
2024
18 d late
2023
on the day
2022
on the day
2021
on the day
2020
2 d early
2018
29 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€513k▲ 22.9%
2024 · €417k
2018: €175klowest value
2020: €180k
2021: €194k▲ +7.7% vs 2020
2022: €207k▲ +6.8% vs 2021
2023: €405k▲ +95.7% vs 2022
2024: €417k▲ +3.1% vs 2023
2025: €513k▲ +22.9% vs 2024highest value
2018 → 2025
Total assets
€1.34M▲ 26.2%
2024 · €1.06M
2018: €332k
2020: €206klowest value
2021: €331k▲ +60.6% vs 2020
2022: €368k▲ +11.3% vs 2021
2023: €834k▲ +126% vs 2022
2024: €1.06M▲ +27.2% vs 2023
2025: €1.34M▲ +26.2% vs 2024highest value
2018 → 2025
Net result
€96k▲ 674%
2024 · €12k
2018: €30k
2020: €5klowest value
2021: €14k▲ +175% vs 2020
2022: €13k▼ -4.7% vs 2021
2023: €198k▲ +1397% vs 2022highest value
2024: €12k▼ -93.8% vs 2023
2025: €96k▲ +674% vs 2024
2018 → 2025
Working capital
€542k▲ 41.1%
2024 · €384k
2018: €168k
2020: €146klowest value
2021: €193k▲ +32.3% vs 2020
2022: €247k▲ +28.3% vs 2021
2023: €326k▲ +31.9% vs 2022
2024: €384k▲ +17.7% vs 2023
2025: €542k▲ +41.1% vs 2024highest value
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€194k-€207k▲ 6.8%€405k▲ 95.7%€417k▲ 3.1%€513k▲ 22.9%
2021: €194klowest in 5 years
2022: €207k▲ +6.8% vs 2021
2023: €405k▲ +95.7% vs 2022
2024: €417k▲ +3.1% vs 2023
2025: €513k▲ +22.9% vs 2024highest in 5 years
Operating result€18k-€27k▲ 54.4%€204k▲ 644%€35k▼ 82.7%€114k▲ 226%
2021: €18klowest in 5 years
2022: €27k▲ +54.4% vs 2021
2023: €204k▲ +644% vs 2022highest in 5 years
2024: €35k▼ -82.7% vs 2023
2025: €114k▲ +226% vs 2024
Net result€14k-€13k▼ 4.7%€198k▲ 1,397%€12k▼ 93.8%€96k▲ 674%
2021: €14k
2022: €13k▼ -4.7% vs 2021
2023: €198k▲ +1397% vs 2022highest in 5 years
2024: €12k▼ -93.8% vs 2023lowest in 5 years
2025: €96k▲ +674% vs 2024
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 226% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.34M
Fixed assets
€268k ▲ 20.7%
Current assets
€1.07M ▲ 27.6%
Equity and liabilities €1.34M
Equity
€513k ▲ 22.9%
Debt
€826k ▲ 28.3%
Debt's share of the balance-sheet total rises from 60.7% to 61.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€229k▲
2024 · €97k
Cash flow
€210k▲
2024 · €74k
Current ratio
2.02▲
2024 · 1.84
Quick ratio
1.65▲
2024 · 1.40
Debt to equity
1.61▲
2024 · 1.54
ROE
18.6%▲
2024 · 3.0%
ROA
7.1%▲
2024 · 1.2%
Interest coverage
12.32▲
2024 · 4.16
Debt ≤ 1 year
€529k▲
2024 · €455k
Debt > 1 year
€297k▲
2024 · €189k
Income taxes
€484
Staff costs
€190k▲
2024 · €85k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.06M€1.34M▲
Fixed assets21/28€222k€268k▲
Intangible fixed assets21€74k€153k▲
Tangible fixed assets22/27€148k€116k▼
Plant, machinery and equipment23€142k€113k▼
Furniture and vehicles24€6k€3k▼
Current assets29/58€839k€1.07M▲
Stocks and contracts in progress3€202k€200k▼
Stocks30/36€202k€200k▼
Amounts receivable within one year40/41€461k€795k▲
Trade receivables40€121k€13k▼
Other amounts receivable41€340k€782k▲
Cash at bank and in hand54/58€175k€75k▼
Deferred charges and accrued income490/1€1k€745▼
Equity and liabilities
Total equity and liabilities10/49€1.06M€1.34M▲
Equity10/15€417k€513k▲
Contributions10/11€19k€19k=
Outside capital11€19k-
Other1109/19€19k-
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14€397k€493k▲
Amounts payable17/49€644k€826k▲
Amounts payable after more than one year17€189k€297k▲
Financial debts170/4€189k€297k▲
Amounts payable within one year42/48€455k€529k▲
Current portion of amounts payable after more than one year42€40k€43k▲
Financial debts43€200k€200k=
Other loans439€200k€200k=
Trade debts44€188k€217k▲
Suppliers440/4€188k€217k▲
Taxes, remuneration and social security45€13k€30k▲
Taxes450/3€1k-
Remuneration and social security454/9€12k€30k▲
Other amounts payable47/48€13k€39k▲
Income statement
Code20242025
Remuneration, social security and pensions62€85k€190k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€62k€114k▲
Other operating charges640/8€5k€370▼
Non-recurring operating charges66A-€32k
Gross operating margin9900€187k€452k▲
Operating profit (loss)9901€35k€114k▲
Financial income75/76B€521€264▼
Recurring financial income75€521€264▼
Financial charges65/66B€23k€19k▼
Recurring financial charges65€23k€19k▼
Profit (loss) for the period before taxes9903€12k€96k▲
Income taxes67/77-€484
Profit (loss) for the period9904€12k€96k▲
Profit (loss) for the period to be appropriated9905€12k€96k▲
Appropriation of the result
Profit (loss) to be appropriated9906€397k€493k▲
Profit (loss) brought forward from the previous period14P€385k€397k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | €31k | €85k | €190k | ▲ 123% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €9k | €21k | €29k | €62k | €114k | ▲ 85.0% |
| Other operating charges640/8 | - | €399 | €271 | €5k | €370 | ▼ 92.2% |
| Non-recurring operating charges66A | - | €4k | - | - | €32k | - |
| Gross operating margin9900 | €27k | €53k | €265k | €187k | €452k | ▲ 141% |
| Operating profit (loss)9901 | €18k | €27k | €204k | €35k | €114k | ▲ 226% |
| Financial income75/76B | - | - | €1 | €521 | €264 | ▼ 49.3% |
| Recurring financial income75 | - | - | €1 | €521 | €264 | ▼ 49.3% |
| Financial charges65/66B | - | €12k | €6k | €23k | €19k | ▼ 20.3% |
| Recurring financial charges65 | €4k | €3k | €6k | €23k | €19k | ▼ 20.3% |
| Non-recurring financial charges66B | - | €10k | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €14k | €15k | €198k | €12k | €96k | ▲ 678% |
| Income taxes67/77 | €0 | €2k | €-484 | - | €484 | - |
| Profit (loss) for the period9904 | €14k | €13k | €198k | €12k | €96k | ▲ 674% |
| Profit (loss) for the period to be appropriated9905 | €14k | €13k | €198k | €12k | €96k | ▲ 674% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €331k | €368k | €834k | €1.06M | €1.34M | ▲ 26.2% |
| Fixed assets21/28 | €109k | €92k | €250k | €222k | €268k | ▲ 20.7% |
| Intangible fixed assets21 | €68k | €61k | €89k | €74k | €153k | ▲ 107% |
| Tangible fixed assets22/27 | €41k | €30k | €160k | €148k | €116k | ▼ 22.2% |
| Plant, machinery and equipment23 | - | €30k | €153k | €142k | €113k | ▼ 20.7% |
| Furniture and vehicles24 | - | €441 | €7k | €6k | €3k | ▼ 57.3% |
| Current assets29/58 | €222k | €277k | €584k | €839k | €1.07M | ▲ 27.6% |
| Stocks and contracts in progress3 | €162k | €193k | €202k | €202k | €200k | ▼ 1.1% |
| Stocks30/36 | - | €193k | €202k | €202k | €200k | ▼ 1.1% |
| Amounts receivable within one year40/41 | €23k | €36k | €51k | €461k | €795k | ▲ 72.5% |
| Trade receivables40 | - | €34k | €42k | €121k | €13k | ▼ 89.6% |
| Other amounts receivable41 | - | €2k | €9k | €340k | €782k | ▲ 130% |
| Cash at bank and in hand54/58 | €34k | €45k | €330k | €175k | €75k | ▼ 56.8% |
| Deferred charges and accrued income490/1 | - | €2k | €1k | €1k | €745 | ▼ 50.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €331k | €368k | €834k | €1.06M | €1.34M | ▲ 26.2% |
| Equity10/15 | €194k | €207k | €405k | €417k | €513k | ▲ 22.9% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Outside capital11 | - | €19k | €19k | €19k | - | - |
| Other1109/19 | - | €19k | €19k | €19k | - | - |
| Reserves13 | €2k | €2k | €2k | €2k | €2k | = |
| Non-distributable reserves130/1 | - | €2k | €2k | €2k | €2k | = |
| Reserves not available under the articles1311 | - | €2k | €2k | €2k | €2k | = |
| Profit (loss) carried forward14 | €173k | €186k | €385k | €397k | €493k | ▲ 24.1% |
| Amounts payable17/49 | €137k | €161k | €429k | €644k | €826k | ▲ 28.3% |
| Amounts payable after more than one year17 | €108k | €102k | €171k | €189k | €297k | ▲ 57.4% |
| Financial debts170/4 | - | €102k | €171k | €189k | €297k | ▲ 57.4% |
| Amounts payable within one year42/48 | €29k | €29k | €258k | €455k | €529k | ▲ 16.3% |
| Current portion of amounts payable after more than one year42 | - | €18k | €178k | €40k | €43k | ▲ 6.6% |
| Financial debts43 | - | - | - | €200k | €200k | = |
| Other loans439 | - | - | - | €200k | €200k | = |
| Trade debts44 | €4k | €1k | €68k | €188k | €217k | ▲ 15.4% |
| Suppliers440/4 | - | €1k | €68k | €188k | €217k | ▲ 15.4% |
| Taxes, remuneration and social security45 | - | €2k | €4k | €13k | €30k | ▲ 124% |
| Taxes450/3 | - | €2k | - | €1k | - | - |
| Remuneration and social security454/9 | - | - | €4k | €12k | €30k | ▲ 147% |
| Other amounts payable47/48 | - | €8k | €8k | €13k | €39k | ▲ 193% |
| Accrued charges and deferred income492/3 | - | €30k | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €14k | €13k | €198k | €12k | €96k | ▲ 674% |
| + Depreciation and write-downs630 | €9k | €21k | €29k | €62k | €114k | ▲ 85.0% |
| Operating cash flow (approximation) | €23k | €34k | €227k | €74k | €210k | ▲ 183% |
| Investment in fixed assets (approximation) | - | €-4k | €-187k | €-34k | €-160k | ▼ 366% |
| Change in cash | - | €11k | €285k | €-155k | €-99k | ▲ 36.1% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 2 days late
2025
30-06
Financial
Equity above €500kEq €513k ▲22.9%
7 profitable years in a row build equity to €513k.
18-02
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 18 days late
2024
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Highest result since 2018net €198k ▲1,397%
Operating result €204k, net result €198k, both a record.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial
Equity above €200kEq €207k ▲6.8%
4 profitable years in a row build equity to €207k.
31-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
29-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Weakest financial yearnet €5k ▼83%
Net result drops to €5k, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity triplescurrent ratio 6.56
Current ratio from 2.07 to 6.56; short-term debt falls from €157k to €26k.
2019
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
Show earlier events
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 10 days late
2017
26-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 57 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chaumont-Gistoux · 1 establishment unit since 2008
Ground area
4,635 m²
Building footprint
229 m²
Parcel 25021G0006/00H000, Wallonia. Linked by address, not a title deed.
1 establishment unit
ImmunoChem
since 20082.210.420.063
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25021G0006/00H000 | Wallonia | 4,635 m² | 1 · 229 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ZENDA
BE 0870.474.931
Roeselare · Eq €512k
BAHIA TRADING
BE 0502.709.725
Aalst · Eq €517k
POTCHELLI-SEMPRE
BE 0474.522.812
Grobbendonk · Eq €508k
PIANO'S DRIESEN
BE 0455.098.165
Maasmechelen · Eq €520k
ATRONIC'S
BE 0440.961.703
Herve · Eq €504k
Of 1,173 companies in sector 46499 we hold annual accounts for 743. 540 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-03-2008
Fiscal year end30-06
Activities, NACEBEL 2025
46499Wholesale of other household goods
72109Other research and development on natural sciences
81300Landscape service activities
86910Medical imaging and medical laboratories
Contact
Scores and ratios are computed by Checked and are not a credit decision.